SHC Stock Overview
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.
Sotera Health Company Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$20.27|
|52 Week High||US$27.38|
|52 Week Low||US$17.73|
|1 Month Change||9.63%|
|3 Month Change||3.84%|
|1 Year Change||-15.54%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-19.24%|
Recent News & Updates
Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M
Sotera Health press release (NASDAQ:SHC): Q2 GAAP EPS of $0.11 misses by $0.05. Revenue of $266.64M (+5.8% Y/Y) beats by $10.34M. Adjusted EBITDA for the second-quarter 2022 increased 1.2% over the second quarter of 2021 to $136M. FY 2022 Guidance: Net revenues in the range of $1.0 to $1.022 billion, from previous guidance of $1.0 to $1.03 billion, representing growth of approximately 7% to 10%, compared to the prior year, vs. consensus of $1.02B Adjusted EBITDA in the range of $515 to $525 million, from previous guidance of $515 to $535 million, representing growth of approximately 7% to 9%, compared to the prior year Adjusted EPS in the range of $0.93 to $0.97 from previous guidance of $0.93 to $0.99 representing growth of 6% to 10% versus the prior year, vs. consensus of $0.96. Capital expenditures in the range of $140 million to $170 million
|SHC||US Life Sciences||US Market|
Return vs Industry: SHC exceeded the US Life Sciences industry which returned -19.8% over the past year.
Return vs Market: SHC underperformed the US Market which returned -10.2% over the past year.
|SHC Average Weekly Movement||6.4%|
|Life Sciences Industry Average Movement||10.8%|
|Market Average Movement||7.7%|
|10% most volatile stocks in US Market||16.9%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: SHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SHC's weekly volatility (6%) has been stable over the past year.
About the Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company’s sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries.
Sotera Health Company Fundamentals Summary
|SHC fundamental statistics|
Is SHC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SHC income statement (TTM)|
|Cost of Revenue||US$432.00m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.44|
|Net Profit Margin||12.68%|
How did SHC perform over the long term?See historical performance and comparison